Dementia/Alzheimer Disease
RSSArticles
-
News From the End-of-Life: Medicare program touts hospice benefits
-
Neurostimulation and Cognition
Direct current transcranial stimulation of the human brain holds promise for helping to improve a variety of neurological functions, including learning and memory. -
Adult Seizures and Social Outcomes of Children with Partial Complex Seizures
Early and aggressive treatment of seizures, educational and social habilitation, as well as treatment of psychiatric comorbidities is advisable in intellectually normal children with focal epilepsy (partial complex seizures with or without secondary generalization). -
Pharmacology Watch: Is This the End of the Road for Calcium Supplementation?
Calcium supplementation in women; type 2 diabetes treatments and pancreatitis risk; treating chronic idiopathic urticaria; rivaroxaban and VTE; and FDA actions. -
Stroke Alert: A Review of Current Clinical Stroke Literature
Environmental and Lifestyle Impact on Stroke Risk -
Medial Thalamic Dysregulation in Idiopathic Restless Legs Syndrome
There is a reduced N-acetylaspartate/creatine-phosphocreatine ratio and N-acetylaspartate concentration at the level of the medial thalamus in patients with restless legs syndrome (RLS), suggesting involvement of the limbic system in the pathophysiology of RLS. -
Clinical Briefs in Primary Care Supplement
-
Subcutaneous IVIG for Chronic Inflammatory Demyelinating Polyneuropathy
s the subcutaneous administration of immunoglobulin (SCIG) as safe and effective as intravenous immunoglobulin (IVIG) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) as it is for multifocal motor neuropathy and primary immune disorders? -
Clinical Briefs in Primary Care supplement
-
A Newly Discovered Genetic Cause of Alzheimer’s Disease Mutations of TREM2
Inflammation is thought to play a role in alzheimers disease (AD) pathogenesis. Evidence of inflammation is seen in AD brains, including activated microglia, cytokines, and complement components.